NEW YORK, NY / ACCESSWIRE / July 12, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the lead plaintiff deadlines listed below to petition the court, and those interested in their eligibility are encouraged to contact the firm. There will be no cost or obligation to you.
Metro Bank PLC (MBNKF)
Lawsuit on behalf of: investors who purchased March 6, 2018 - May 1, 2019
Lead Plaintiff Deadline : July 29, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/metro-bank-plc-loss-form?prid=2363&wire=1.
According to the filed complaint, during the class period, Metro Bank PLC made materially false and/or misleading statements and/or failed to disclose that: (1) Metro Bank misclassified the risk terms of many of its loans; (2) accordingly, Metro Bank failed to maintain sufficient capital; (3) this conduct would lead to investigations by the PRA and FCA; (4) this conduct would also lead to the reduction of deposits at Metro Bank from larger commercial and partnership clients; and (5) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.
Momo Inc. (MOMO)
Lawsuit on behalf of: investors who purchased April 21, 2014 - April 29, 2019
Lead Plaintiff Deadline : July 15, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/momo-inc-loss-form?prid=2363&wire=1.
According to the filed complaint, during the class period, Momo Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Momo’s compliance procedures and controls were inadequate to prevent, inter alia, illicit financial reporting activity; (ii) Momo’s social and dating app, Tantan, was materially noncompliant with PRC law and/or regulations; (iii) Tantan was consequently at an increased risk of being removed from Chinese app stores at the direction of Chinese governmental authorities; and (iv) as a result, Momo’s public statements were materially false and misleading at all relevant times.
Teva Pharmaceutical Industries Ltd. (TEVA)
Lawsuit on behalf of: investors who purchased on behalf of all persons or entities who purchased or otherwise acquired Teva American Depositary Shares (“ADS”) between August 4, 2017 and May 10, 2019
Lead Plaintiff Deadline : August 23, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/teva-pharmaceutical-industries-ltd-loss-form?prid=2363&wire=1.
According to the filed complaint, (i) contrary to its public denials, Teva had in fact engaged in a vast, industry-wide price-fixing scheme and other collusive misconduct since at least 2012; (ii) Teva was not only a participant, but the company at the heart of the anticompetitive scheme; and (iii) several Teva employees had such deep involvement in the scheme that they would ultimately be named personally as defendants in a sweeping civil enforcement action filed by the AGs of virtually every state in the nation.
You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
SOURCE: Levi & Korsinsky, LLP